O	0	6	Effect
O	7	9	of
B-condition	10	16	Weight
I-condition	17	21	Loss
O	22	26	with
O	27	29	or
O	30	37	without
B-intervention	38	46	Exercise
O	47	49	on
O	50	62	Inflammatory
O	63	70	Markers
O	71	74	and
O	75	85	Adipokines
O	86	88	in
O	89	103	Postmenopausal
O	104	109	Women
O	109	110	:
O	111	114	The
O	115	120	SHAPE
O	120	121	-
O	121	122	2
O	123	128	Trial
O	128	129	,
O	130	131	A
O	132	142	Randomized
O	143	153	Controlled
O	154	159	Trial
O	159	160	.

O	161	163	We
O	164	176	investigated
O	177	180	the
O	181	187	effect
O	188	190	of
O	191	201	equivalent
O	202	208	weight
O	209	213	loss
O	213	214	,
O	215	217	by
O	218	219	a
O	220	231	hypocaloric
O	232	236	diet
O	237	239	or
O	240	246	mainly
O	247	255	exercise
O	255	256	,
O	257	259	on
O	260	272	inflammatory
O	273	280	markers
O	281	284	and
O	285	295	adipokines
O	296	298	in
O	299	309	overweight
O	310	324	postmenopausal
O	325	330	women
O	330	331	.

O	332	337	Women
O	338	342	were
O	343	353	randomized
O	354	356	to
O	357	358	a
O	359	363	diet
O	364	365	(
O	365	366	n
O	367	368	=
B-intervention-participants	369	371	97
O	371	372	)
O	372	373	,
O	374	380	mainly
O	381	389	exercise
O	390	391	(
O	391	392	n
O	393	394	=
B-intervention-participants	395	397	98
O	397	398	)
O	398	399	,
O	400	402	or
B-control	403	410	control
I-control	411	416	group
O	417	418	(
O	418	419	n
O	420	421	=
B-control-participants	422	424	48
O	424	425	)
O	425	426	.

O	427	431	Goal
O	432	434	of
O	435	439	both
O	440	453	interventions
O	454	457	was
O	458	460	to
O	461	465	lose
O	466	467	5
O	468	470	to
O	471	472	6
O	473	475	kg
O	476	486	bodyweight
O	487	489	by
O	490	491	a
O	492	503	hypocaloric
O	504	508	diet
O	509	511	or
O	512	514	an
O	515	523	exercise
O	524	531	program
O	532	533	(
O	533	534	4
O	535	540	hours
O	540	541	/
O	541	545	week
O	545	546	)
O	547	555	combined
O	556	560	with
O	561	562	a
O	563	568	small
O	569	576	caloric
O	577	583	intake
O	584	595	restriction
O	595	596	.

O	597	605	Outcomes
O	606	611	after
O	612	614	16
O	615	620	weeks
O	621	629	included
B-outcome-Measure	630	635	serum
I-outcome-Measure	636	640	high
I-outcome-Measure	640	641	-
I-outcome-Measure	641	650	sensitive
I-outcome-Measure	651	652	C
I-outcome-Measure	652	653	-
I-outcome-Measure	653	661	reactive
I-outcome-Measure	662	669	protein
I-outcome-Measure	670	671	(
I-outcome-Measure	671	676	hsCRP
I-outcome-Measure	676	677	)
O	677	678	,
B-outcome-Measure	679	682	IL6
O	682	683	,
B-outcome-Measure	684	695	adiponectin
O	695	696	,
O	697	700	and
B-outcome-Measure	701	707	leptin
O	707	708	.

O	709	713	Both
O	714	726	intervention
O	727	733	groups
O	734	742	achieved
O	743	746	the
O	747	753	target
O	754	760	weight
O	761	765	loss
O	765	766	.

O	767	775	Controls
O	776	784	remained
O	785	791	weight
O	792	798	stable
O	798	799	.

O	800	808	Compared
O	809	813	with
O	814	821	control
O	821	822	,
B-outcome	823	828	hsCRP
O	829	838	decreased
O	839	843	with
O	844	850	mainly
O	851	859	exercise
O	860	861	[
O	861	870	treatment
O	871	877	effect
O	878	883	ratio
O	884	885	(
O	885	888	TER
O	888	889	)
O	890	891	=
O	892	893	0
O	893	894	.
O	894	896	64
O	896	897	]
O	898	901	and
O	902	912	borderline
O	913	926	statistically
O	927	938	significant
O	939	943	with
O	944	948	diet
O	949	950	(
O	950	953	TER
O	954	955	=
O	956	957	0
O	957	958	.
O	958	960	77
O	960	961	)
O	961	962	.

O	963	968	There
O	969	972	was
O	973	974	a
O	975	987	suggestively
O	988	994	larger
O	995	1001	effect
O	1002	1004	of
O	1005	1013	exercise
O	1013	1014	,
O	1015	1023	directly
O	1024	1032	compared
O	1033	1037	with
O	1038	1042	diet
O	1043	1044	(
O	1044	1047	TER
O	1048	1049	=
O	1050	1051	0
O	1051	1052	.
O	1052	1054	83
O	1054	1055	)
O	1055	1056	.

B-outcome	1057	1063	Leptin
O	1064	1073	decreased
O	1074	1078	with
O	1079	1083	both
O	1084	1097	interventions
O	1097	1098	:
O	1099	1105	mainly
O	1106	1114	exercise
O	1115	1116	(
O	1116	1119	TER
O	1120	1121	=
O	1122	1123	0
O	1123	1124	.
O	1124	1126	55
O	1126	1127	)
O	1128	1131	and
O	1132	1136	diet
O	1137	1138	(
O	1138	1141	TER
O	1142	1143	=
O	1144	1145	0
O	1145	1146	.
O	1146	1148	59
O	1148	1149	)
O	1149	1150	,
O	1151	1157	versus
O	1158	1165	control
O	1165	1166	.

O	1167	1174	Effects
O	1175	1185	attenuated
O	1186	1189	and
O	1190	1194	lost
O	1195	1207	significance
O	1208	1213	after
O	1214	1223	adjusting
O	1224	1227	for
O	1228	1234	change
O	1235	1237	in
O	1238	1242	body
O	1243	1246	fat
O	1247	1257	percentage
O	1257	1258	,
O	1259	1262	and
O	1263	1265	to
O	1266	1267	a
O	1268	1274	lesser
O	1275	1281	extent
O	1282	1286	when
O	1287	1296	adjusting
O	1297	1300	for
O	1301	1308	fitness
O	1308	1309	.

O	1310	1312	No
O	1313	1320	effects
O	1321	1325	were
O	1326	1330	seen
O	1331	1333	on
B-outcome	1334	1337	IL6
I-outcome	1338	1341	and
I-outcome	1342	1353	adiponectin
O	1353	1354	.

O	1355	1356	A
O	1357	1359	16
O	1359	1360	-
O	1360	1364	week
O	1365	1375	randomized
O	1376	1388	intervention
O	1389	1397	inducing
O	1398	1408	comparable
O	1409	1415	weight
O	1416	1420	loss
O	1421	1423	by
O	1424	1425	a
O	1426	1437	hypocaloric
O	1438	1442	diet
O	1443	1445	or
O	1446	1452	mainly
O	1453	1461	exercise
O	1461	1462	,
O	1463	1471	resulted
O	1472	1474	in
O	1475	1484	favorable
O	1485	1492	effects
O	1493	1495	on
B-outcome	1496	1501	serum
I-outcome	1502	1507	hsCRP
I-outcome	1508	1511	and
I-outcome	1512	1518	leptin
O	1518	1519	.

O	1520	1522	We
O	1523	1528	found
O	1529	1530	a
O	1531	1539	possible
O	1540	1544	more
O	1545	1555	beneficial
O	1556	1562	effect
O	1563	1565	on
O	1566	1571	hsCRP
O	1572	1576	with
O	1577	1583	mainly
O	1584	1592	exercise
O	1593	1599	versus
O	1600	1604	diet
O	1604	1605	.

O	1606	1611	These
O	1612	1619	effects
O	1620	1622	of
O	1623	1631	exercise
O	1632	1636	were
O	1637	1648	established
O	1649	1651	by
O	1652	1659	changes
O	1660	1662	in
O	1663	1667	body
O	1668	1671	fat
O	1672	1682	percentage
O	1683	1686	and
O	1687	1695	physical
O	1696	1703	fitness
O	1703	1704	.

O	1705	1706	A
O	1707	1713	modest
O	1714	1720	amount
O	1721	1723	of
O	1724	1730	weight
O	1731	1735	loss
O	1736	1738	in
O	1739	1753	postmenopausal
O	1754	1759	women
O	1760	1767	reduces
O	1768	1773	hsCRP
O	1774	1777	and
O	1778	1784	leptin
O	1785	1791	levels
O	1792	1797	which
O	1798	1803	might
O	1804	1806	be
O	1807	1817	associated
O	1818	1822	with
O	1823	1824	a
O	1825	1830	lower
O	1831	1837	breast
O	1838	1844	cancer
O	1845	1849	risk
O	1849	1850	.

O	1851	1857	Cancer
O	1858	1867	Epidemiol
O	1868	1878	Biomarkers
O	1879	1883	Prev
O	1883	1884	;
O	1885	1887	25
O	1887	1888	(
O	1888	1889	5
O	1889	1890	)
O	1890	1891	;
O	1892	1895	799
O	1895	1896	-
O	1896	1899	806
O	1899	1900	.

O	1901	1902	Â©
O	1902	1906	2016
O	1907	1911	AACR
O	1911	1912	.
